Oncobit
PrivateLast Round
Early Funding
Nov 27, 2025
Total Funding Raised
$6.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Oncobit AG is a medtech company that has developed a scalable, data-driven cancer monitoring platform based on the quantitative and sensitive detection of cancer markers in liquid biopsies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oncobit Comparables
Compare Oncobit with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hedera Dx | 87% | |
| ID SOLUTIONS | 77% | |
| Sysmex Corporation | 74% |
Oncobit Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 27, 2025 | ||||
| Early Funding | Nov 20, 2024 | ||||
| Seed | Apr 29, 2021 |
Key People
Founding team and executive leadership
Oncobit Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avanteca Partners | Seed |
| ID SOLUTIONS | Early Funding |
| GF Group Holding | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 104% MoM, reaching 1.6K.
- Jul 25, 2026
Monthly visitors grew 105% MoM.
Recent news
Latest coverage and updates
- hiresJun 23, 2026
Oncobit AG hires Bram Goorden as Chairman.
Oncobit Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Oncobit's valuation, stock price, and market status.
Is Oncobit a public or private company?
Oncobit is a private company.
What is the current stock price of Oncobit?
Oncobit is a private company with no public stock price. No recent secondary market data is available.
How much is Oncobit worth (valuation)?
Valuation information for Oncobit is not publicly available.
Can I buy Oncobit stock?
Oncobit shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Oncobit's last funding round?
Oncobit's most recent funding round was Early Funding on November 27, 2025.
Who are the main investors in Oncobit?
Key investors in Oncobit include Avanteca Partners, ID SOLUTIONS, GF Group Holding.
Will Oncobit IPO soon?
No public IPO plans have been announced for Oncobit.
How can I track Oncobit secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oncobit's secondary market activity and sign up for updates.